branded tirzepatide (Mounjaro) In Sherman Oaks Tirzepatide 60mg/3mL (20mg/mL) | Pipeline
Description
Clinical evidence suggests that patients may experience a substantial reduction in body weight, with some studies indicating an average loss of around 15% over a 68-week period

Compounded Medication Notice: Compounded medications referenced in this article are not FDA-approved finished drug products

Lopez-JimenezFAlmahmeedWBaysHCuevasADi AngelantonioELe RouxCWet alObesity and cardiovascular disease: mechanistic insights and management strategies

doi: 10.1002/alz.12088 [DOI] [PubMed] [Google Scholar] 46

Compounding pharmacies create customized medications by combining, mixing, or altering ingredients, and under specific circumstances defined by the Federal Food, Drug, and Cosmetic Act, they may compound versions of FDA-approved drugs
